Document Detail


Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study.
MedLine Citation:
PMID:  21884947     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: We sought to determine clinical and demographic predictors of recovery of left ventricular function for subjects with recent onset cardiomyopathy (ROCM).
BACKGROUND: Although ROCM is a frequent reason for consultation and transplantation referral, its prognosis and natural history on contemporary therapy are unknown.
METHODS: In the multicenter IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study, subjects with a left ventricular ejection fraction (LVEF) of ≤0.40, fewer than 6 months of symptom duration, and an evaluation consistent with idiopathic dilated cardiomyopathy or myocarditis were enrolled. LVEF was reassessed at 6 months, and subjects were followed up for 4 years. LVEF and event-free survival were compared by race, sex, and clinical phenotype.
RESULTS: The cohort of 373 persons was 38% female and 21% black, with a mean age of 45 ± 14 years. At entry, 91% were receiving angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and 82% were receiving beta-blockers, which increased to 92% and 94% at 6 months. LVEF was 0.24 ± 0.08 at entry and 0.40 ± 0.12 at 6 months (mean increase: 17 ± 13 ejection fraction units). Transplant-free survival at 1, 2, and 4 years was 94%, 92%, and 88%, respectively; survival free of heart failure hospitalization was 88%, 82%, and 78%, respectively. In analyses adjusted for sex, baseline LVEF, and blood pressure, LVEF at 6 months was significantly lower in blacks than in nonblacks (p = 0.02). Left ventricular end-diastolic diameter at presentation was the strongest predictor of LVEF at 6 months (p < 0.0001).
CONCLUSIONS: Outcomes in ROCM are favorable but differ by race. Left ventricular end-diastolic diameter by transthoracic echo at presentation was most predictive of subsequent myocardial recovery. (Genetic Modulation of Left Ventricular Recovery in Recent Onset Cardiomyopathy; NCT00575211).
Authors:
Dennis M McNamara; Randall C Starling; Leslie T Cooper; John P Boehmer; Paul J Mather; Karen M Janosko; John Gorcsan; Kevin E Kip; G William Dec;
Related Documents :
18831897 - Eprosartan in the primary prevention of cardiac allograft vascular disease: a double-bl...
22693127 - Cavitation of deep lacunar infarcts in patients with first-ever lacunar stroke: a 2-yea...
22543837 - Perioperative myocardial necrosis in patients at high cardiovascular risk undergoing el...
21254897 - Role of complement and perspectives for intervention in ischemia-reperfusion damage.
18831897 - Eprosartan in the primary prevention of cardiac allograft vascular disease: a double-bl...
3567367 - Segment analysis of human coronary arteries.
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  58     ISSN:  1558-3597     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-09-02     Completed Date:  2011-10-24     Revised Date:  2012-10-09    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1112-8     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Affiliation:
Cardiovascular Institute, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA. mcnamaradm@upmc.edu
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00575211
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
African Americans
Cardiomyopathy, Dilated / ethnology*
Diastole
Female
Humans
Male
Middle Aged
Multivariate Analysis
Prospective Studies
Recovery of Function*
Sex Factors
United States / epidemiology
Ventricular Function, Left
Grant Support
ID/Acronym/Agency:
HL075038/HL/NHLBI NIH HHS; HL086918/HL/NHLBI NIH HHS; HL69912/HL/NHLBI NIH HHS; K24 HL069912/HL/NHLBI NIH HHS; R01 HL075038/HL/NHLBI NIH HHS
Comments/Corrections
Comment In:
J Am Coll Cardiol. 2012 Feb 21;59(8):776; author reply 776-7   [PMID:  22340272 ]
Erratum In:
J Am Coll Cardiol. 2011 Oct 18;58(17):1832

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  First experience with drug-eluting balloons in infrapopliteal arteries restenosis rate and clinical ...
Next Document:  Lipolytic effects of B-type natriuretic peptide(1-32) in adipose tissue of heart failure patients co...